Literature DB >> 29742179

Demographic and Tumor Characteristics of Patients Younger Than 50 Years With Nonmelanoma Skin Cancer Referred for Mohs Micrographic Surgery.

Nicola A Quatrano, Euphemia W Mu, David E Orbuch, Adele Haimovic, Roy G Geronemus, Jeremy A Brauer.   

Abstract

BACKGROUND: An increase in nonmelanoma skin cancer (NMSC) in younger patients has been reported. Many are treated with Mohs micrographic surgery (MMS).
OBJECTIVE: Investigate patient and tumor characteristics in patients less than 50 years undergoing MMS for NMSC at a large, referral-based practice. METHODS & MATERIALS: Retrospective chart review of 1,332 tumors occurring in 1,018 consecutive patients over a five-year period.
RESULTS: 81.7% of tumors were BCC and 55.3% occurred in women. Patients less than 30 years were more likely to be female (P equals 0.016) and women were more likely to have BCC (P equals 0.010). SCCs were more likely with increasing age (P less than 0.001). Of all tumors, 3.6% were recurrent, 2.7% had diameters ≥ 2 centimeters, and 5.5% of all BCCs had a high-risk histologic subtype. Women were more than twice as likely as men to be referred to plastic surgery for repair (P equals 0.020).
CONCLUSION: Patients < 50 years with NMSC may represent a growing population referred for MMS, especially young women with BCC. High-risk tumor features were rare among young patients, and female gender was associated with an increased rate of referral for repair by a plastics subspecialty. Study was performed at the Laser &amp; Skin Surgery Center of New York. IRB STATUS: Approved by Essex Institutional Review Board, Protocol #MOHS40-65 <p><em>J Drugs Dermatol. 2018;17(5):499-505.</em></p>.

Entities:  

Mesh:

Year:  2018        PMID: 29742179

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  1 in total

1.  Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery: A Prospective, Multicenter Cohort Study.

Authors:  Amanda Maisel-Campbell; Katherine A Lin; Sarah A Ibrahim; Bianca Y Kang; Noor Anvery; McKenzie A Dirr; Rachel E Christensen; Juliet L Aylward; Omar Bari; Hamza Bhatti; Diana Bolotin; Basil S Cherpelis; Joel L Cohen; Sean Condon; Sheila Farhang; Bahar Firoz; Algin B Garrett; Roy G Geronemus; Nicholas J Golda; Tatyana R Humphreys; Eva A Hurst; Oren H Jacobson; S Brian Jiang; Pritesh S Karia; Arash Kimyai-Asadi; David J Kouba; James G Lahti; Martha Laurin Council; Marilyn Le; Deborah F MacFarlane; Ian A Maher; Stanley J Miller; Eduardo K Moioli; Meghan Morrow; Julia Neckman; Timothy Pearson; Samuel R Peterson; Christine Poblete-Lopez; Chad L Prather; Jennifer S Ranario; Ashley G Rubin; Chrysalyne D Schmults; Andrew M Swanson; Christopher Urban; Y Gloria Xu; Murad Alam; Simon Yoo; Emily Poon; Vishnu Harikumar; Alexandra Weil; Sanjana Iyengar; Matthew R Schaeffer
Journal:  JAMA Dermatol       Date:  2022-07-01       Impact factor: 11.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.